Table 1 Demographic and clinical characteristics of study participants.
ALS group | Control group | |
|---|---|---|
Number | 108 | 90 |
Age, median (SD) | 52.83(9.49) | 51.63 (9.68) |
Gender (Male/Female) | 65/43 | 46/44 |
Site of onset (%) | ||
Bulbar | 13 (12.0) | |
Cervical | 74 (68.5) | |
Lumbosacral | 21 (19.4) | |
ALSFRS-R score, median (SD) | 39.3 (5.87) | |
Bulbar ALSFRS-R score | 10.7 (2.02) | |
Upper limb ALSFRS-R score | 7.7 (3.27) | |
Lower limb ALSFRS-R score | 9.1 (2.73) | |
Disease duration in months, median (SD) | 14.69 (11.98) | |
El Escorial score (%) | ||
Definite | 20 (18.5) | |
Probable | 58 (53.7) | |
Probable-lab supported | 20 (18.5) | |
Possible | 10 (9.3) | |
